Chicago Partners Investment Group’s Quest Diagnostics DGX Stock Holding History

Chicago Partners Investment Group’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$801K	Buy	3,514 +244	+7%	+$47.9K	0.02%	758
2026 Q1	$667K	Sell	3,270 -87	-3%	-$16.9K	0.01%	728
2025 Q4	$608K	Sell	3,357 -90	-3%	-$16.4K	0.02%	662
2025 Q3	$614K	Buy	3,447 +2,013	+140%	+$357K	0.02%	589
2025 Q2	$245K	Buy	1,434 +288	+25%	+$50K	0.01%	941
2025 Q1	$202K	Buy	+1,146	New	+$188K	0.01%	868
2023 Q3	–	Sell	-1,512	Closed	-$204K	–	669
2023 Q2	$204K	Buy	+1,512	New	+$208K	0.01%	637
2015 Q2	–	Sell	-28	Closed	-$2K	–	452
2015 Q1	$2K	Buy	28 +4	+17%	+$286	﹤0.01%	463
2014 Q4	$2K	Buy	+24	New	+$1.51K	﹤0.01%	501

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Chicago Partners Investment Group's DGX Position: Q2 2026 in Review

Chicago Partners Investment Group increased its Quest Diagnostics (DGX) stake by 7.5% in Q2 2026, buying an estimated $47.9K and bringing the position to 3,514 shares worth $801K. The position accounts for 0.02% of the portfolio, ranked #758.

Chicago Partners Investment Group first reported a position in DGX in Q4 2014 and has held it in 9 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Chicago Partners Investment Group held 3,514 shares of Quest Diagnostics worth $801K as of Q2 2026.
Chicago Partners Investment Group bought 244 Quest Diagnostics shares in Q2 2026, an estimated $47.9K.
Quest Diagnostics made up 0.02% of Chicago Partners Investment Group's portfolio in Q2 2026, its #758 holding.
Chicago Partners Investment Group first reported a position in Quest Diagnostics in Q4 2014 and has held it in 9 quarters since.
1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Chicago Partners Investment Group's 13F filing for Q2 2026, filed 30 Jul 2026.